975165

Niagara Pharmaceuticals Inc — FEI 3003093882

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 16, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dundas (Canada)

Citations

IDCFRDescription
179621 CFR 211.80(d)Identification of Each Lot in Each Shipment
188321 CFR 211.165(a)Testing and release for distribution